HSBC Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

HSBC Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.93M	Sell	70,000 -40,000	-36%	-$4.99M	﹤0.01%	963
2025 Q4	$13.5M	Buy	+110,000	New	+$12.6M	0.01%	865
2024 Q3	–	Sell	-164,300	Closed	-$15.2M	–	3183
2024 Q2	$15.2M	Buy	+164,300	New	+$14.7M	0.01%	750
2023 Q4	–	Sell	-614,100	Closed	-$44.8M	–	2944
2023 Q3	$44.8M	Buy	614,100 +200,600	+49%	+$16M	0.05%	393
2023 Q2	$34.6M	Buy	+413,500	New	+$34.6M	0.04%	482
2022 Q3	–	Sell	-51,700	Closed	-$3.88M	–	3309
2022 Q2	$3.88M	Buy	+51,700	New	+$3.88M	0.01%	1300
2020 Q2	–	Sell	-23,400	Closed	-$1.81M	–	2893
2020 Q1	$1.81M	Buy	23,400 +19,500	+500%	+$1.73M	﹤0.01%	1214
2019 Q4	$372K	Sell	3,900 -1,100	-22%	-$95.2K	﹤0.01%	2406
2019 Q3	$381K	Buy	+5,000	New	+$416K	﹤0.01%	2482

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HSBC Holdings's XBI Position: Q1 2026 in Review

HSBC Holdings increased its State Street SPDR S&P Biotech ETF (XBI) stake by 14% in Q1 2026, buying an estimated $10.9M and bringing the position to 725,538 shares worth $92.6M. The position accounts for 0.05% of the portfolio, ranked #355.

HSBC Holdings first reported a position in XBI in Q2 2013 and has held it in 51 quarters since. The position peaked at $103M in Q4 2023. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

HSBC Holdings held 725,538 shares of State Street SPDR S&P Biotech ETF worth $92.6M as of Q1 2026.
HSBC Holdings bought 87,009 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $10.9M.
State Street SPDR S&P Biotech ETF made up 0.05% of HSBC Holdings's portfolio in Q1 2026, its #355 holding.
HSBC Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 51 quarters since.
HSBC Holdings's State Street SPDR S&P Biotech ETF position peaked at $103M in Q4 2023.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.